JPRN-UMIN000046400已完成Unknown
A Clinical Trial to Validate the Efficacy of Monitoring Blood Glucose, Diet, and Physical Activity in Patients with Prediabetes - A Clinical Trial to Validate the Efficacy of Monitoring Blood Glucose, Diet, and Physical Activity in Patients with Prediabetes
iigata University0 个研究点目标入组 179 人开始时间: 2022年9月30日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 179
研究概览
简要总结
TIR for blood glucose 70-140 mg/dL improved more in the App group than in the C group (-2.6 min/day vs +31.5 min/day, p=0.03). BMI (-0.26 vs. -0.59, p=0.02) reduced in the App compared to the C, and the rate of weight loss of 2 kg or more was reduced in the App compared to the C.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. those under treatment for diabetes mellitus 2. those undergoing cancer treatment 3. those taking adrenal corticosteroids 4. other persons deemed inappropriate by the physician
研究者
相似试验
已完成
不适用
Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active CancerHematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmType 2 Diabetes MellitusNCT04938869Ohio State University Comprehensive Cancer Center3
终止
3 期
MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)Diabetes Mellitus, Type 2NCT00543816Merck Sharp & Dohme LLC100
已完成
不适用
The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.Type 2 DiabetesNCT06111508University of Virginia30
已完成
不适用
Continuous Glucose Monitoring As Adjunct to Lifestyle Modification in PrediabetesPreDiabetesNCT04588896Chinese University of Hong Kong177
已完成
4 期
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)Metabolic SyndromeHypertensionNCT00234858Abbott280